Quantification of succinylacetone in urine of hepatorenal tyrosinemia patients by HPLC with fluorescence detection

Clinica Chimica Acta

Volumn 365, Issue 1-2, 2006, Pages 243-248

  Al Dirbashi, Osama Y ^a   Jacob, Minnie ^a   Al Ahaidib, Lujane Y ^a   Al Qahtani, Khaled ^a   Rahbeeni, Zuhair ^a   Al Owain, M ^a   Rashed, Mohamed S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Fluorescence detector; HPLC; Succinylacetone; Tyrosinemia

Indexed keywords

5,7 DIOXOOCTANOIC ACID; HYDRAZIDE DERIVATIVE; OCTANOIC ACID DERIVATIVE; PYRENEBUTYRIC HYDRAZIDE; SUCCINYLACETONE; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CONTROLLED STUDY; FLUORESCENCE; HEPATORENAL SYNDROME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; TYROSINEMIA; URINALYSIS;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEPTANOATES; HUMANS; KIDNEY DISEASES; LIVER DISEASES; SPECTROMETRY, FLUORESCENCE; TYROSINEMIAS;

EID: 32144440313     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.09.001     Document Type: Article

References (24)

1. M. Lelong, D. Alagille, C.I. Gentil, J. Collin, V. Le Tan, and J.C. Gabilan Cirrhose congenitale et familiale avec diabete phospho-gluco-amine, rachitismine vitamin D-resistant et tyrosinurie massive Rev Francisc Etud Clin Biol 8 1963 37 50
2. E. Kvittingen Tyrosinemia type I-an update J Inherit Metab Dis 14 1991 554 562
3. B. Lindblad, S. Lindstedt, and G. Steen On the enzymic defects in hereditary tyrosinemia Proc Natl Acad Sci U S A 74 1977 4641 4645
4. R. Berger, G.P. Smit, S.A. Stocker-devries, M. Duram, D. Ketting, and S.k. Wadman Deficiency of fumarylacetoacetase in patient with hereditary tyrosinemia Clin Chim Acta 114 1981 37 44
5. G.A. Mitchell, M. Lambert, and R. Tanguay Hypertyrosinemia C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular bases of inherited disease seventh ed. 1995 McGraw-Hill New York 1087 1095
6. E. Holme, and S. Lindstedt Diagnosis and management of tyrosinemia type I Curr Opin Pediatr 7 1995 726 732
7. E.A. Kvittingen Tyrosinemia - treatment and outcome J Inherit Metab Dis 18 1995 375 379
8. S. Lindstedt, E. Holme, E.A. Lock, O. Hjalmarson, and B. Strandvik Treatment of hereditary tyrosinemia type I by inhibition of 4- hydroxyphenylpyruvate dioxygenase Lancet 340 1992 813 817
9. M. Tuchman, C.B. Whitley, M.L. Ramnaraine, L.D. Bowers, K.D. Fregien, and W. Krivit Determination of urinary succinylacetone by capillary gas chromatography J Chromatogr Sci 22 1984 211 215
10. A. Grenier, A. Lescault, C. Laberge, R. Gagne, and O. Mamer Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia Clin Chim Acta 123 1982 93 99
11. C. Jakobs, L. Dorland, B. Wikkerink, R.M. Kok, A.P.J.M. de Jong, and S.K. Wadman Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and post neonatal diagnosis of hereditary tyrosinemia type I Clin Chim Acta 171 1988 223 231
12. H. Schierbeek, and R. Berger Determination of succinylacetone and SAA in physiological samples as the common product 5(3)-methyl-3(5)-isoxazole propionic acid using an isotope dilution method and mass spectrometry Clin Chim Acta 184 1989 243 250
13. A.L. Shroads, G.N. Henderson, J. Cheung, M.O. James, and P.W. Stacpoole Unified gas chromatographic-mass spectrometric method for quantitating tyrosine metabolites in urine and plasma J Chromatogr B 808 2004 153 161
14. M.S. Casever, and F.B. Erim Determination of urinary succinylacetone by capillary electrophoresis for the diagnosis of tyrosinemia type I J Chromatogr B 818 2005 309 311
15. M.S. Rashed, M. Al-Sayed, and Z. Rahbeeni Quantitative analysis of succinylacetone in urine by liquid chromatography electrospray tandem mass spectrometry J Inherit Metab Dis 26 suppl 2 2003 196
16. M.S. Rashed, L. Al-Ahaidib, and O. Al-Dirbashi Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia Anal Biochem 339 2005 310 317
17. M.S. Rashed Clinical applications of tandem mass spectrometry: ten of diagnosis and screening for inherited metabolic diseases J Chromatogr B 758 2001 27 48
18. K.J. Goulden, M.A. Moss, D.E. Cole, G.A. Tithecott, and J.F. Crocker Pitfalls in the initial diagnosis of tyrosinemia: three case reports and a review of the literature Clin Biochem 20 1987 207 212
19. A. Schulze, D. Frommhold, G.F. Hoffmann, and E. Mayatepek Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I Clin Chem 47 2001 1424 1429
20. P. Allard, A. Grenier, M.S. Korson, and T.H. Zytkovicz Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots Clin Biochem 37 2004 1010 1015
21. O.Y. Al-Dirbashi, M. Jacob, Z. Al-Hassnan, F. El-Badaoui, and M.S. Rashed Diagnosis of methylmalonic acidemia from dried blood spots by HPLC and intramolecular-excimer fluorescence derivatization Clin Chem 51 2005 235 237
22. O.Y. Al-Dirbashi, M. Jacob, and M. Al-Amoudi Quantification of glutaric and 3-hydroxyglutaric acids in urine of glutaric acidemia type I patients by HPLC with intramolecular excimer-forming fluorescence derivatization Clin Chim Acta 359 2005 179 188
23. H. Nohta, H. Satozono, K. Koiso, H. Yoshida, J. Ishida, and M. Yamaguchi Highly selective fluorometric determination of polyamines based on intramolecular excimer-forming derivatization with a pyrene-labeling reagent Anal Chem 72 2000 4199 4204
24. H. Nohta, J. Sonoda, H. Yoshida, H. Satozono, J. Ishida, and M. Yamaguchi Liquid chromatographic determination of dicarboxylic acids based on intramolecular excimer-forming fluorescence derivatization J Chromatogr A 1010 2003 37 44